The Patent Finder

Mainline Biosciences, Inc.

Also on record
Records under this name other than the patents Mainline Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 5 of 5 · Back to Mainline Biosciences, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,870,681CXCR4 antagonists and methods of use
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,351,601CXCR4 antagonists and methods of use
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,639,379High affinity CXCR4 selective binding conjugate and method for using the same
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,883,501Selective CXCR4 binding peptide conjugate and methods for making and using the same
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,123,437Selective CXCR4 binding peptide conjugate and methods for making and using the same
Formerly held
Lapsed on the fee record
Ended Sep 21, 2025 · USPTO record
Lapsed on the fee recordEnded Sep 21, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited